Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Farmers Insurance
Queensland Health
Boehringer Ingelheim
Citi
Cantor Fitzgerald
Teva
Chinese Patent Office
Healthtrust

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,599,557

« Back to Dashboard

Summary for Patent: 5,599,557
Title: Stable hydrated cephalosporin dry powder for oral suspension formulation
Abstract:A dry hydrated cephalosporin, e.g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
Inventor(s): Johnson; Donald A. (Miami Lakes, FL), Wearley; Lorraine (Westfield, NJ), Galeos; Rebecca (Bloomfield, NJ), Sequeira; Joel A. (New York, NY)
Assignee: Schering Corporation (Kenilworth, NJ)
Application Number:08/325,400
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Process; Dosage form;

Drugs Protected by US Patent 5,599,557

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,599,557

PCT Information
PCT FiledApril 30, 1993PCT Application Number:PCT/US93/03856
PCT Publication Date:November 11, 1993PCT Publication Number: WO93/21923

International Patents Family Members for US Patent 5,599,557

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 150310 ➤ Try a Free Trial
Australia 4115293 ➤ Try a Free Trial
Australia 674516 ➤ Try a Free Trial
Canada 2134467 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Boehringer Ingelheim
UBS
Chubb
Federal Trade Commission
US Army
QuintilesIMS
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.